BMY
BRISTOL MYERS SQUIBB COC5815-min delayed · EOD close——as of —
Pharmaceutical Preparations · SIC 2834 · CIK 0000014272
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $50.0B | 2026-09-30 | 10-Q · 0000014272-26-000024 |
| Revenue (prior year) | $48.3B | 2024-12-31 | 10-K · 0000014272-25-000039 |
| Gross profit | $30.7B | 2020-12-31 | 10-K · 0000014272-21-000066 |
| Net income | $9.2B | 2026-09-30 | 10-Q · 0000014272-26-000024 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $88.8B | 2026-09-30 | 10-Q · 0000014272-26-000024 |
| Current assets | $29.8B | 2026-09-30 | 10-Q · 0000014272-26-000024 |
| Total liabilities | $65.4B | 2026-09-30 | 10-Q · 0000014272-26-000024 |